[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606138":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":33,"locations":41,"responsibleParty":60,"collaborators":64,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":24,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":44,"whyStopped":24,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"School of Health Sciences Geneva","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group 1: Sensitization to Cervical Cancer (CC) screening","EXPERIMENTAL","Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment.",[13],"Behavioral: Sensitization to Cervical Cancer (CC) screening",{"label":15,"type":10,"description":16,"interventionNames":17},"Intervention Group 2: Home-based HPV self-sampling","Women will receive a free-of-charge vaginal self-sampling kit for HPV infection.",[18],"Behavioral: Home-based HPV self-sampling",[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"BEHAVIORAL","Sensitization to Cervical Cancer (CC) screening",[9],null,{"type":21,"name":26,"description":16,"armGroupLabels":27,"otherNames":24},"Home-based HPV self-sampling",[15],[29],{"name":30,"affiliation":31,"role":32},"Jessica Di Vincenzo Sormani, PhD","Haute École de Santé de Genève (HEdS-GE)","STUDY_DIRECTOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":24,"email":38},"Jessica Di Vincenzo-Sormani, PhD","CONTACT","+41 22 558 58 78","jessica.di-vincenzo-sormani@hesge.ch",{"name":40,"role":36,"phone":24,"phoneExt":24,"email":24},"Patrick Petignat, MD",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"University Hospitals of Geneva","RECRUITING","Geneva","Canton of Geneva","1205","Switzerland","CH",{"type":51,"coordinates":52},"Point",[53,54],6.14569,46.20222,{"lat":54,"lon":53},[57],{"name":40,"role":36,"phone":58,"phoneExt":24,"email":59},"+41 22 372 44 32","patrick.petignat@hug.ch",{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"SPONSOR_INVESTIGATOR","Jessica Di Vincenzo Sormani","Professor assistant (tenure track)",[65],{"name":66,"class":6},"University Hospital, Geneva","100606138","breast-cancer-related-approach-for-increasing-cervical-cancer-screening-100606138",false,"NCT07171658","Breast Cancer-Related Approach for Increasing Cervical Cancer Screening","Improving Cervical Cancer Screening Coverage Among Underscreened Women Aged 50 to 74 in Switzerland Using HPV Self-sampling Strategies: A Randomized Study - Breast Cancer-Related Approach for Increasing Cervical Cancer Screening","BRAICS","Inclusion Criteria:\n\n* Women receiving Breast Cancer Screening (BCS) invitation letters in the selected five cantons (Geneva, Bern (francophone), Jura, Neuchâtel, and Vaud)\n* Aged 50 to 74 years old\n* Not been screened for cervical cancer in the past three years\n* Speaking one of the 6 languages of the study (French, German, Italian, and in English, Spanish, and Portuguese)\n\nExclusion Criteria:\n\n* Prior cervical cancer diagnosis,\n* Hysterectomy\n* Non consent to participate to the study\n* Incapable of judgment or under tutelage\n* Pregnancy",true,"FEMALE","50 Years","74 Years",{"count":80,"type":81},4500,"ESTIMATED","INTERVENTIONAL",[84],"NA","The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland.\n\nThis randomized trial will compare three arms:\n\n1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment.\n2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection\n3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.",[87],"Cervical Cancer Screening",[89,90,91,92],"cervical cancer screening","underscreened women","HPV self-sampling","Integrated approach","2025-12-15",{"date":95,"type":96},"2025-12-22","ACTUAL",{"date":98,"type":96},"2025-10-07",{"date":100,"type":81},"2027-12-31",{"name":62,"class":6},1]